GAMMA Investing’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

GAMMA Investing’s Portfolio CANF Stock Details CANF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$14.8K	Buy	+6,706	New	+$20.2K	﹤0.01%	3123

Other funds holding CANF

AWM

Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

GAMMA Investing's CANF Position: Q3 2026 in Review

GAMMA Investing opened a new position in Can-Fite BioPharma American Depositary Shares (CANF) in Q3 2026: 6,706 shares worth $14.8K. The stake represents ﹤0.01% of the portfolio and ranks #3123 among its holdings.

3 funds tracked by Wall St. Rank hold CANF as of Q3 2026.

GAMMA Investing held 6,706 shares of Can-Fite BioPharma American Depositary Shares worth $14.8K as of Q3 2026.
Can-Fite BioPharma American Depositary Shares was a new GAMMA Investing position in Q3 2026.
Can-Fite BioPharma American Depositary Shares made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3123 holding.
3 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.